These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11461999)

  • 21. Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication.
    Schang LM
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):197-209. PubMed ID: 15023361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics.
    de la Fuente C; Maddukuri A; Kehn K; Baylor SY; Deng L; Pumfery A; Kashanchi F
    Curr HIV Res; 2003 Apr; 1(2):131-52. PubMed ID: 15043199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin-dependent kinase activity is required for efficient expression and posttranslational modification of human cytomegalovirus proteins and for production of extracellular particles.
    Sanchez V; Spector DH
    J Virol; 2006 Jun; 80(12):5886-96. PubMed ID: 16731927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral activity of CYC202 in HIV-1-infected cells.
    Agbottah E; de La Fuente C; Nekhai S; Barnett A; Gianella-Borradori A; Pumfery A; Kashanchi F
    J Biol Chem; 2005 Jan; 280(4):3029-42. PubMed ID: 15531588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.
    Schang LM; Rosenberg A; Schaffer PA
    J Virol; 1999 Mar; 73(3):2161-72. PubMed ID: 9971799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors.
    Diwan P; Lacasse JJ; Schang LM
    J Virol; 2004 Sep; 78(17):9352-65. PubMed ID: 15308730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons.
    Monaco EA; Beaman-Hall CM; Mathur A; Vallano ML
    Biochem Pharmacol; 2004 May; 67(10):1947-64. PubMed ID: 15130771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.
    Wesierska-Gadek J; Gueorguieva M; Wojciechowski J; Horky M
    Pol J Pharmacol; 2004; 56(5):635-41. PubMed ID: 15591654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride.
    Sato T; Asamitsu K; Yang JP; Takahashi N; Tetsuka T; Yoneyama A; Kanagawa A; Okamoto T
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):293-8. PubMed ID: 9519889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication.
    Bresnahan WA; Boldogh I; Chi P; Thompson EA; Albrecht T
    Virology; 1997 May; 231(2):239-47. PubMed ID: 9168886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Caspase-3 plays a required role in PC12 cell apoptotic death induced by roscovitine].
    Gao JX; Zhou YQ; Zhang RH; Ma XL; Liu KJ
    Sheng Li Xue Bao; 2005 Dec; 57(6):755-60. PubMed ID: 16344902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors.
    Wang L; Deng L; Wu K; de la Fuente C; Wang D; Kehn K; Maddukuri A; Baylor S; Santiago F; Agbottah E; Trigon S; Morange M; Mahieux R; Kashanchi F
    Mol Cell Biochem; 2002 Aug; 237(1-2):137-53. PubMed ID: 12236581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of polyamine oxidase prevented cyclin-dependent kinase inhibitor-induced apoptosis in HCT 116 colon carcinoma cells.
    Gürkan AC; Arisan ED; Obakan P; Palavan-Ünsal N
    Apoptosis; 2013 Dec; 18(12):1536-47. PubMed ID: 23892915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases.
    Kotala V; Uldrijan S; Horky M; Trbusek M; Strnad M; Vojtesek B
    Cell Mol Life Sci; 2001 Aug; 58(9):1333-9. PubMed ID: 11577989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
    Schutte B; Nieland L; van Engeland M; Henfling ME; Meijer L; Ramaekers FC
    Exp Cell Res; 1997 Oct; 236(1):4-15. PubMed ID: 9344580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of G1/S-phase and late S-phase checkpoints with regulation of cyclin-dependent kinases in Chinese hamster ovary cells.
    D'Anna JA; Valdez JG; Habbersett RC; Crissman HA
    Radiat Res; 1997 Sep; 148(3):260-71. PubMed ID: 9291358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cells.
    Hahntow IN; Schneller F; Oelsner M; Weick K; Ringshausen I; Fend F; Peschel C; Decker T
    Leukemia; 2004 Apr; 18(4):747-55. PubMed ID: 14973497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roscovitine, a novel cyclin-dependent kinase inhibitor, characterizes restriction point and G2/M transition in tobacco BY-2 cell suspension.
    Planchais S; Glab N; Tréhin C; Perennes C; Bureau JM; Meijer L; Bergounioux C
    Plant J; 1997 Jul; 12(1):191-202. PubMed ID: 9263460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical inhibitors of cyclin-dependent kinases.
    Meijer L
    Prog Cell Cycle Res; 1995; 1():351-63. PubMed ID: 9552377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.